4-acetamido-3-fluorobenzaldehyde thiosemicarbazone | 475150-57-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-acetamido-3-fluorobenzaldehyde thiosemicarbazone
• 英文别名: N-[4-[(E)-(carbamothioylhydrazinylidene)methyl]-2-fluorophenyl]acetamide
• CAS: 475150-57-3
• 化学式: C₁₀H₁₁FN₄OS
• 分子量: 254.288
• InChiKey: LPOOMGIKZQEQHR-WLRTZDKTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  112
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  氨基硫脲 、 4-acetylamino-3-fluoro-benzaldehyde 以 乙醇 、 水 、 溶剂黄146 为溶剂， 生成 4-acetamido-3-fluorobenzaldehyde thiosemicarbazone
  参考文献：
  名称：

  Halogenated antituberculosis agents

  摘要：

  合成了两种合成抗结核病药物硫代乙酰唑和对氨基水杨酸的卤代衍生物。一般来说，卤代化合物具有结构I：其中X1是卤素，X2是第二个卤素或氢，Y是硫或氧;或者具有结构IV：其中X1是卤素，X2是第二个卤素或氢。或者，这些卤代化合物可以是这些化合物的药学上可接受的盐。这些卤代衍生物具有抗分枝杆菌活性，特别适用于治疗结核分枝杆菌感染。特别是，合成了硫代乙酰唑和对氨基水杨酸的氟代类似物，可单独或与其他传统的抗结核病治疗药物联合使用作为抗结核病治疗药物。

  公开号：

  US06482982B1

文献信息

• HALOGENATED ANTITUBERCULOSIS AGENTS
  申请人：——

  公开号：US20020173548A1

  公开（公告）日：2002-11-21

  Halogenated derivatives of two synthetic anti-tuberculosis agents, thioacetazone and p-aminosalicylic acid, have been synthesized. In general, the halogenated compound has the structure of Structure I: 1 wherein X 1 is a halogen and X 2 is a second halogen or hydrogen, and Y is sulfur or oxygen; or, has the structure of Structure IV: 2 wherein X 1 is a halogen and X 2 is a second halogen or hydrogen. Alternatively, the halogenated compounds may be pharmaceutically acceptable salts of these compounds. These halogenated derivatives possess anti-mycobacterial activity and are particularly useful for the treatment of Mycobacterium tuberculosis infections. In particular, fluorinated analogs of thioacetazone and p-amino-salicylic acid have been synthesized for use as anti-tuberculosis therapeutic agents either alone or in combination with other conventional anti-tuberculosis therapeutic agents.

  已经合成了两种合成抗结核药物硫代乙酰唑和对氨基水杨酸的卤代衍生物。一般来说，卤代化合物具有结构I：1的结构，其中X1是卤素，X2是第二个卤素或氢，Y是硫或氧；或者，具有结构IV：2的结构，其中X1是卤素，X2是第二个卤素或氢。或者，这些卤代化合物可以是这些化合物的药物可接受的盐。这些卤代衍生物具有抗分枝杆菌活性，特别适用于治疗结核分枝杆菌感染。特别是，已经合成了硫代乙酰唑和对氨基水杨酸的氟化类似物，用于作为抗结核治疗剂，单独使用或与其他常规抗结核治疗剂联合使用。
• US6482982B1
  申请人：——

  公开号：US6482982B1

  公开（公告）日：2002-11-19
• US6624153B2
  申请人：——

  公开号：US6624153B2

  公开（公告）日：2003-09-23
• [EN] HALOGENATED ANTITUBERCULOSIS AGENTS<br/>[FR] AGENTS ANTITUBERCULEUX HALOGENES
  申请人：UNIV THE SCIENCES IN PHILADELP

  公开号：WO2002092019A2

  公开（公告）日：2002-11-21

  Halogenated derivatives of two synthetic anti-tuberculosis agents, thioacetazone and p-aminosalicylic acid, have been synthesized. In general, the halogenated compound has the structure of Structure (I), wherein X1 is a halogen and X2 is a second halogen or hydrogen, and Y is sulfur or oxygen;or, has the structure of Structure (IV), wherein X1 is a halogen and X2 is a second halogen or hydrogen. Alternatively, the halogenated compounds may be pharmaceutically acceptable salts of these compounds. These halogenated derivates possess anti-mycobacterial activity and are particularly useful for the treatment of Mycobacterium tuberculosis infections. In particular, fluorinated analogs of thioacetazone and p-aminosalicylic acid have been synthesized for use as anti-tuberculosis therapeutic agents either alone or in combination with other conventional anti-tuberculosis therapeutic agents.
• Halogenated antituberculosis agents
  申请人：University of Sciences of Philadelphia

  公开号：US06482982B1

  公开（公告）日：2002-11-19

  Halogenated derivatives of two synthetic anti-tuberculosis agents, thioacetazone and p-aminosalicylic acid, have been synthesized. In general, the halogenated compound has the structure of Structure I: wherein X1 is a halogen and X2 is a second halogen or hydrogen, and Y is sulfur or oxygen; or, has the structure of Structure IV: wherein X1 is a halogen and X2 is a second halogen or hydrogen. Alternatively, the halogenated compounds may be pharmaceutically acceptable salts of these compounds. These halogenated derivatives possess anti-mycobacterial activity and are particularly useful for the treatment of Mycobacterium tuberculosis infections. In particular, fluorinated analogs of thioacetazone and p-amino-salicylic acid have been synthesized for use as anti-tuberculosis therapeutic agents either alone or in combination with other conventional anti-tuberculosis therapeutic agents.

  合成了两种合成抗结核病药物硫代乙酰唑和对氨基水杨酸的卤代衍生物。一般来说，卤代化合物具有结构I：其中X1是卤素，X2是第二个卤素或氢，Y是硫或氧;或者具有结构IV：其中X1是卤素，X2是第二个卤素或氢。或者，这些卤代化合物可以是这些化合物的药学上可接受的盐。这些卤代衍生物具有抗分枝杆菌活性，特别适用于治疗结核分枝杆菌感染。特别是，合成了硫代乙酰唑和对氨基水杨酸的氟代类似物，可单独或与其他传统的抗结核病治疗药物联合使用作为抗结核病治疗药物。